Analysis
Social concerns increasingly important in European consumer M&A
Ethical supply chains, modern slavery, diversity and inclusion, wage gaps, and health and safety are all "potential liabilities" for M&A sponsors
Spotlight on Spacs: Fintech fever
A sustained surge in fintech deal-making may well have Spacs to thank
Fund financing and ESG: from the impact niche to the mainstream
ESG-linked fund financing facilities are becoming a prominent – and well publicised – tool in the ESG toolbox for GPs and lenders
GP Profile: Gyrus looks to next steps after debut pandemic fundraise
Co-founder Guy Semmens discusses the GP's first-time fundraise, its deal pipeline, and the lead-up to its next fund
UK social care reform: threat or opportunity for PE?
PE players and advisers with experience in the care space weigh in on whether the reform is likely to affect investments
European sports get lifeline from PE funds
European sports teams are diving into the hands of financial sponsors, inspiring an unprecedented run of form for M&A in the space
Spotlight on Spacs: UK hopes slow and steady wins the race
Exuberance at the prospect of an incoming wave of Spac listings may be premature, but not necessarily irrational
GP Profile: HPE Growth sets the stage for next fundraise
Manfred Krikke and Tim van Delden on the firm's growth plans, fundraising intentions, and the importance of European digital technology
Podcast: In conversation with… Adam Turtle, Rede Partners
Turtle joins the podcast to discuss the firm's journey over its first decade and the main trends in the European fundraising landscape
Valuations rising as food & beverage whets PE's appetite
Within the space of a year, average pricing in the space has increased by 2.2 turns of EBITDA, research by Clearwater and Unquote shows
UK remains priciest PE market in Europe
LTM average entry multiple for UK buyouts stood at 13.2x in Q2 - up by nearly two and a half turns of EBITDA year-on-year
Aurelius plans string of Italian acquisitions following office opening
Ideal targets will be family companies looking to be guided in their growth plans, new MD says
Unquote Private Equity Podcast: Climb in pricing persists
Following the publication of the Q2 2021 Multiples Heatmap, Unquote welcomes Clearwater's executive team to discuss pricing trends
Video: Q&A with Rutland Partners' David Wardrop
David Wardrop joins Unquote editor Greg Gille to discuss how the firm is approaching the post-Covid investment landscape
Podcast: In conversation with… Kerry Baldwin, IQ Capital & BVCA
New BVCA chair discusses her priorities for the year ahead, the buoyant environment for venture, how to improve PE's public image, and more
VC Profile: DN Capital set to deploy in buoyant European VC market
Managing partner and co-founder Nenad Marovac discusses the firm's deployment plans and its view of the European VC market
Unquote Private Equity Podcast: H1 review special
The team looks at key takeaways and numbers across deal-doing and fundraising, and ponders where the market might be headed
GP Profile: FSI back on the hunt for deals
CEO Maurizio Tamagnini discusses FSI's approach to the post-pandemic market to identify new investments, and its plans for a second fund
Morrisons rival bidders may have little room to improve on Fortress bid
Both CD&R and Apollo are seen as viable threats to Fortress’s offer, one source says
Spotlight on Spacs: Green power
With an expanded investor universe flush with cash, green may well prove to be gold for Europe's blank-cheque future
GP Profile: Summa Equity
Reynir Indahl believes GPs should move beyond ticking ESG boxes to 'impact-weighted' reporting
Multiples continue to climb in Nordic region as activity booms
Nordic PE market saw record levels of deal value in Q1, with valuations soaring even higher on the back of renewed optimism
GP Profile: Palatine looks to B2B, continued ESG value creation
Managing partner Gary Tipper discusses the firm's deal pipeline, its focus on ESG, and how its portfolio has weathered the pandemic
Healthcare valuations heat up as high-profile assets crystallise competition
Healthcare sector saw multiple valuations pick up in Q1 2021 and hit a record high of 13.7x